Systemic Lupus Erythematosus: The Most Common Rare Disease - European Medical Journal

Systemic Lupus Erythematosus: The Most Common Rare Disease

The EMJ Podcast | Episode 139

In this episode, Jonathan is joined by Chris Wincup, Versus Arthritis Clinical Research Fellow in Rheumatology, Department of Rheumatology, University College London, UK. They discuss the current treatments for systemic lupus erythematosus (SLE), as well as symptoms. They also consider mental health in patients with SLE, and the effect that the COVID-19 pandemic has had on patients with SLE and autoimmune diseases.

Spotify | Apple | Amazon MusicDownload MP3 (mp3, 43:28 mins)

 

Speaker bio:

Chris Wincup earned his BSc in Biomedical Sciences from the University of Brighton, UK, and his medical degree from the Brighton and Sussex Medical School, a medical school in the UK that was formed as a partnership between the University of Brighton and University of Sussex. Since then, he has been awarded multiple prizes, including the Royal Society of Medicine (RSM) Kovac’s Travelling Fellowship Award and the Imperial Award for quality of teaching at Northwick Park Hospital, London, UK.

Wincup is on the British Society for Paediatric and Adolescent Rheumatology (BSPAR) committee, is Chair of the British Rheumatologists in Training Society, and is also involved with Arthritis Research UK, where he acts as content reviewer and media spokesman. He has published numerous articles, abstracts, and book chapters, and is on the editorial board for multiple medical journals.

While Wincup went into medicine, most of his family work in brewing. Wincup is a football fan and supports Norwich City. He lives in Norwich with his wife and their two dachshunds, Chip and Frank.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.